Breaking Barriers: A New Frontier in Treating Chronic Kidney Disease

Chronic kidney disease affects millions, yet half of those diagnosed lack the common driver of diabetes, leaving many without specialized treatment options. In this episode, we explore the groundbreaking FIND-CKD clinical trial led by Professor Hiddo Lambers Heerspink. We analyze how the drug finerenone is changing the landscape for non-diabetic patients, offering a significant reduction in the risk of kidney failure, heart complications, and cardiovascular death. Join us as we break down the science behind this study, the impressive results regarding kidney function preservation, and what this means for the future of nephrology and patient care.

📥 Connect with The...